George Tziras
Net worth: 165 029 $ as of 31/05/2026
Net worth: 165 029 $ as of 31/05/2026
George Tziras currently works at Small Pharma, Inc., as Chief Executive Officer & Director from 2022, Cybin UK Ltd., as Non-Executive Director from 2015, and Cybin, Inc., as Chief Business Officer from 2025.
Mr. Tziras also formerly worked at Unilock Capital Corp., as Chief Business Officer & Director.
Mr. Tziras received his undergraduate degree from the University of Oxford and graduate degree from The Paul H.
Nitze School of Advanced International Studies.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYBIN, INC. 0.07% | 20/02/2026 | 36,270 ( 0.07% ) | 165 029 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SMALL PHARMA INC. | Chief Executive Officer | 20/07/2022 |
| CYBIN INC. | Corporate Officer/Principal | 23/10/2023 |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Director/Board Member | 01/01/2015 |
| Companies | Position | End |
|---|---|---|
| SMALL PHARMA INC. | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Paul H. Nitze School of Advanced International Studies
The Paul H. Nitze School of Advanced International Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops rapid-acting antidepressant | Health Technology |
Unilock Capital Corp.
Unilock Capital Corp. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Cybin, Inc.
Cybin, Inc. Pharmaceuticals: MajorHealth Technology Manufactures neurological pharmaceuticals | Health Technology |
Small Pharma, Inc.
Small Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a neuro pharmaceutical company that develops therapeutic treatments for mental health disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions